70 related articles for article (PubMed ID: 22151983)
1. Cytogenetic analysis of de novo CD5-positive diffuse large B-cell lymphoma.
Kaneko H; Shimura K; Horiike S; Kuroda J; Matsumoto Y; Yokota S; Nishida K; Ohkawara Y; Taniwaki M
Asia Pac J Clin Oncol; 2011 Dec; 7(4):346-50. PubMed ID: 22151983
[TBL] [Abstract][Full Text] [Related]
2. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
[TBL] [Abstract][Full Text] [Related]
3. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
[TBL] [Abstract][Full Text] [Related]
4. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization.
Karnan S; Tagawa H; Suzuki R; Suguro M; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2004 Jan; 39(1):77-81. PubMed ID: 14603444
[TBL] [Abstract][Full Text] [Related]
5. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
[TBL] [Abstract][Full Text] [Related]
6. De novo CD5-positive diffuse large B-cell lymphoma: clinical characteristics and therapeutic outcome.
Yamaguchi M; Ohno T; Oka K; Taniguchi M; Ito M; Kita K; Shiku H
Br J Haematol; 1999 Jun; 105(4):1133-9. PubMed ID: 10554834
[TBL] [Abstract][Full Text] [Related]
7. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the immunoglobulin heavy chain gene variable region of CD5-positive diffuse large B-cell lymphoma.
Nakamura N; Hashimoto Y; Kuze T; Tasaki K; Sasaki Y; Sato M; Abe M
Lab Invest; 1999 Aug; 79(8):925-33. PubMed ID: 10462030
[TBL] [Abstract][Full Text] [Related]
9. Numerical chromosomal abnormality in gastric MALT lymphoma and diffuse large B-cell lymphoma.
Watanobe I; Takamori S; Kojima K; Fukasawa M; Beppu T; Futagawa S; Hirai S
J Gastroenterol; 2002; 37(9):691-6. PubMed ID: 12375141
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas.
Cigudosa JC; Parsa NZ; Louie DC; Filippa DA; Jhanwar SC; Johansson B; Mitelman F; Chaganti RS
Genes Chromosomes Cancer; 1999 Jun; 25(2):123-33. PubMed ID: 10337996
[TBL] [Abstract][Full Text] [Related]
11. Characterization of chromosomal aberrations in diffuse large B-cell lymphoma (DLBL) by G-banding and spectral karyotyping (SKY).
Adam P; Steinlein C; Schmid M; Haralambieva E; Stocklein H; Leich E; Rosenwald A; Muller-Hermelink HK; Ott G
Cytogenet Genome Res; 2006; 114(3-4):274-8. PubMed ID: 16954666
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma.
Hyo R; Tomita N; Takeuchi K; Aoshima T; Fujita A; Kuwabara H; Hashimoto C; Takemura S; Taguchi J; Sakai R; Fujita H; Fujisawa S; Ogawa K; Motomura S; Suzuki R; Ishigatsubo Y
Hematol Oncol; 2010 Mar; 28(1):27-32. PubMed ID: 19358143
[TBL] [Abstract][Full Text] [Related]
13. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
14. Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.
Fiskvik I; Aamot HV; Delabie J; Smeland EB; Stokke T; Heim S; Holte H
Eur J Haematol; 2013 Oct; 91(4):332-8. PubMed ID: 23859481
[TBL] [Abstract][Full Text] [Related]
15. An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome.
Murase T; Nakamura S; Kawauchi K; Matsuzaki H; Sakai C; Inaba T; Nasu K; Tashiro K; Suchi T; Saito H
Br J Haematol; 2000 Dec; 111(3):826-34. PubMed ID: 11122144
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetics and fluorescence in situ hybridization studies of diffuse large B-cell lymphoma in children and young adults.
Dave BJ; Weisenburger DD; Higgins CM; Pickering DL; Hess MM; Chan WC; Sanger WG
Cancer Genet Cytogenet; 2004 Sep; 153(2):115-21. PubMed ID: 15350300
[TBL] [Abstract][Full Text] [Related]
17. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
[TBL] [Abstract][Full Text] [Related]
18. De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.
Cioc AM; Jessurun J; Vercellotti GM; Pambuccian SE
Diagn Cytopathol; 2014 Mar; 42(3):259-67. PubMed ID: 23007953
[TBL] [Abstract][Full Text] [Related]
19. Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma.
Hough RE; Goepel JR; Alcock HE; Hancock BW; Lorigan PC; Hammond DW
Br J Cancer; 2001 Feb; 84(4):499-503. PubMed ID: 11207045
[TBL] [Abstract][Full Text] [Related]
20. CD5 negative and CD5 positive splenic marginal B-cell lymphomas have differential cytogenetic patterns.
Gimeno E; Salido M; Solé F; Florensa L; Granada I; Domingo A; Woessner S
Leuk Res; 2005 Aug; 29(8):981-2. PubMed ID: 15978952
[No Abstract] [Full Text] [Related]
[Next] [New Search]
